Fagron’s strategy is focused on optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide. As the leading global company in pharmaceutical compounding, we are supporting the unique selling point of customized medication and improving patients’ quality of life.
As the leading company in pharmaceutical compounding, Fagron develops innovative concepts and solutions that respond to the specific and individual wishes of compounding pharmacies all over the world. In Fagron’s Innovation department, over 200 pharmacists are dedicated to developing and providing innovative concepts, products and formulas that will meet the demands of the pharmacist, prescriber and patient.

Rotterdam, NL
Size (employees)
2,334 (est)
Fagron was founded in 1990 and is headquartered in Rotterdam, NL

Fagron Office Locations

Fagron has an office in Rotterdam
Rotterdam, NL (HQ)
182 Lichtenauerlaan

Fagron Financials and Metrics

Fagron Financials


Market capitalization (22-Mar-2017)

830.5 b

Closing share price (22-Mar-2017)

Fagron's current market capitalization is €830.5 b.
Show all financial metrics

Fagron Market Value History

Fagron's Web-traffic and Trends

Fagron Online and Social Media Presence

Fagron Company Life and Culture

You may also be interested in